Introduction
Tissue-specific regulation of the human aromatase P450 (CYP19) gene expression is a key step in controlling the local and circulating levels of estrogen and the diverse physiological impacts of the hormone on different parts of the body (Kamat et al., 2002; Simpson et al., 2002) .
Human aromatase gene is expressed in multiple tissues including ovary, bone, adipose tissue, brain, and various fetal tissues (Simpson and Davis, 2001) . Emerging evidence also suggests a role of estrogen synthesized intratumorally in promoting breast cancer development (Sasano and Harada, 1998) . Expression of aromatase is controlled by tissue-specific promoters and alternative splicing (Bulun et al., 2003) . Aromatase produced in ovarian granulosa cells, which is responsible for the biosynthesis of circulating estrogen in premenopausal women, is expressed via the action of a gonad-specific promoter (PII). Interestingly, the same ovary-specific PII promoter is activated in breast tumors and believed to be responsible for the elevated intratumoral aromatase gene expression (Sasano and Harada, 1998) . Therefore, elucidation of the underlying mechanisms that dictate regulation of the aromatase PII promoter is of importance to the understanding of the basis for many hormone-mediated physiological and pathological conditions.
Proliferation and differentiation of ovarian granulosa cells are pivotal to many aspects of ovary functions, including folliculogenesis and steroidogenesis (Richards et al., 1995 (Richards et al., , 1998 . The response of granulosa cells to the pituitary gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), varies significantly during ovarian follicular maturation (Richards, 1994; Richards et al., 1995) . While exposure of preantral or small antral follicles to FSH promotes proliferation of granulosa cells, follicles at the preovulatory (PO) stage respond to FSH by expressing several differentiation-related genes such as aromatase (Cyp19) (Richards, 1994) . In response to FSH, elevation of intracellular cyclic AMP (cAMP) level in granulosa cells leads to activation of the aromatase PII promoter via the combined action of the CREB family of transcription factors and steroidogenic factor 1 (SF-1). Both the CREB and SF-1 transcription factors interact with their corresponding binding sites at the proximal region of the PII promoter (Morohashi et al., 1992; Fitzpatrick and Richards, 1994; Carlone and Richards, 1997; Young and McPhaul, 1997) . Upon the ovarian LH surge, granulosa cells undergo the transition from a proliferating to terminally differentiated state, ultimately becoming luteal cells. This LH-induced transition is accompanied by a rapid reduction in the expression of PO-specific genes including aromatase, as well as induction of gene expression required for ovulation and luteinization (Hickey et al., 1988; Fitzpatrick and Richards, 1991) .
It has become clear that the biological outcomes of gonadotropins are gene-and developmental stagespecific, giving rise to a high degree of complexity in the regulatory pattern of ovarian gene expression (Richards, 1994) . For example, FSH leads to rapid activation of the immediate-early genes such as serum glucocorticoid kinase (SGK), yet delayed expression of some other genes including aromatase (Cyp19) (Woodruff et al., 1987; Delidow et al., 1992; GonzalezRobayna et al., 1999) . Moreover, FSH induces a robust expression of aromatase in granulosa cells of PO follicles, but not in those of preantral follicles (Richards, 1994) . Lastly, many FSH-stimulated genes (e.g. aromatase) in granulosa cells are downregulated in response to the LH surge during the early stages of luteinization (Fitzpatrick and Richards, 1991; Hickey et al., 1988) . While the positive transcription factors that mediate FSH-stimulated transcription of the aromatase gene have been extensively studied, the molecular basis for the attenuation of the aromatase expression is less understood.
AP-1 family of transcription factors consists of homodimers and heterodimers of the Jun and Fos subfamilies that play important roles in diverse aspects of cell proliferation and differentiation (Karin et al., 1997) . Mammalian Jun proteins include c-Jun, JunB, and JunD; Fos proteins include c-Fos, FosB, Fra1, and Fra2. A common characteristic of the AP1 family members is the presence of the basic leucine zipper (bZIP) motif that serves the DNA binding and dimerization functions. The founding members of the AP1 family (i.e. c-Jun and c-Fos) are defined as immediate-early genes, as they are rapidly induced by a variety of stimuli including phorbol ester and growth factors (Shaulian and Karin, 2002) . Previous work has shown that different Jun proteins in ovarian granulosa cells respond to FSH and LH in distinct stage-specific patterns (Sharma and Richards, 2000) . For example, c-Jun, JunB, c-Fos, and Fra2 were rapidly but transiently induced by FSH in immature rat granulosa cells, whereas JunD and Fra2 were induced by LH and their levels were sustained when ovarian granulosa cells were terminally differentiated into luteal cells. These findings have led to the hypothesis that members of the AP1 family may play important functions in ovarian follicular maturation. However, there was no direct evidence for the involvement of AP1 in this regard.
In the current study, we explored functions of the Jun proteins in ovarian gene expression, using a recently established human granulosa-like tumor-derived cell line, KGN (Nishi et al., 2001) . Previous characterization of this cell line clearly shows that it maintains most of the physiological functions of granulosa cells in vivo such as steroidogenesis, cell growth, and apoptosis (Nishi et al., 2001; Mukasa et al., 2003; Chu et al., 2004; Morinaga et al., 2004) , thus validating the utility of this cell line in studying ovarian gene regulation. Our study revealed a potent activity of Jun proteins in downregulating the ovary-specific promoter (PII) of the aromatase gene. Furthermore, our results strongly suggest that Jun proteins attenuate the cAMP-stimulated transcription by directly binding to an essential cAMP responsive element (CRE)-like sequence (CLS) in the ovary-specific promoter.
Results

cAMP-responsive expression of AP1 transcription factors in human granulosa cells
To elucidate the roles of AP1 proteins in gonadotropinresponsive ovarian gene regulation, we first analysed expression of various AP1 family members upon the activation of cAMP-mediated signaling pathway in human ovarian granulosa cells. The KGN granulosalike tumor cell line has been used in previous studies of granulosa cell differentiation and steroidogenesis (Nishi et al., 2001; Mukasa et al., 2003; Chu et al., 2004; Morinaga et al., 2004) . Asynchronously growing cells were treated with either vehicle or 25 mM forskolin, a known activator of adenylyl cyclase, for various periods of time. The messenger RNA levels of several AP1 family members were determined by semiquantitative RT-PCR ( Figure 1A ). JunB and cFos were induced significantly and transiently following forskolin treatment, reaching the peaks of expression by 0.5 h and declining to the basal levels by 3 h post forskolin treatment (panels c and d in Figure 1A ). In contrast, the mRNA levels of cJun, JunD, and Fra2 did not fluctuate substantially (panels a, b, and e). The expression patterns of the Jun proteins were further examined by immunoblotting ( Figure 1B) . Consistent with the mRNA results, the levels of cJun and JunD proteins remained relatively constant throughout the time course study (panels a and b in Figure 1B) . Consistent with the mRNA expression profile, JunB protein was also transiently induced following the forskolin treatment, albeit in a slightly delayed fashion (panel c in Figure 1B ). The expression profiles of the human Jun proteins closely resemble those of the rat counterparts previously observed in forskolin-treated rat granulosa cells (Sharma and Richards, 2000) . The distinct and dynamic expression patterns of the AP1 genes in ovarian granulosa cells are consistent with the notion that they may have a functional impact on ovarian gene expression.
Ectopic Jun proteins repress transcription from the ovary-specific aromatase promoter It is well documented that FSH-responsive gene activation in ovarian granulosa cells occurs in a sequential order, with rapid activation of the immediate-early genes such as c-fos and serum glucocorticoid kinase (SGK) and delayed expression of other genes including aromatase (CYP19) and inhibin a (Woodruff et al., 1987; Delidow et al., 1992; Gonzalez-Robayna et al., 1999) . Indeed, we found that the cAMP-mediated induction of both the aromatase mRNA and protein was considerably delayed in comparison with that of cFos and JunB (compare panel f with d and c in Figure 1A , and d with c in Figure 1B) . Moreover, the surge in the aromatase mRNA and protein expression coincides with the decline of some AP1 family members following their initial induction. This raised the interesting possibility of a causal relationship between these two events. To test this hypothesis, we co-transfected into KGN cells various Jun expression vectors (JunB, cJun, and JunD) and a luciferase reporter plasmid that contains the ovary-specific promoter (PII) of the aromatase gene. As shown in Figure 2a , all three Jun constructs repressed the cAMP-induced transcriptional activation of the aromatase promoter, albeit to different degrees. Titration of the amounts of expression vectors indicated that the Jun-mediated repression was dosedependent (Figure2b and data not shown).
To ascertain that the Jun-mediated transcription repression was not due to general promoter squelching, several AP1-responsive luciferase reporter constructs (i.e., AP1-luc, collagenase-luc, and cyclin-D1-luc) were also included in the study. The same amount of JunB expression vector that severely repressed aromatase PII promoter (columns 2 and 4 in the top panel of Figure 3b ) did not inhibit transcription from the control promoters (Figure 3a) . In fact, JunB actually moderately stimulated the synthetic AP1-responsive promoter and the collagenase promoter (compare column 1 with 2, and 3 with 4 in Figure 3a) , suggesting that the Jun-mediated repression was promoter-specific. It was recently reported that transcription of the mouse steroidogenic acute regulatory protein (StAR) gene, another important gene involved in ovarian steroidogenesis, was stimulated by AP1 proteins in mouse Leydig cells (Manna et al., 2004) . When tested in KGN cells, basal transcription from the same promoter was also stimulated by JunB and c-Jun (compare column 1 with 3 and 5 in bottom panel of Figure 3b ). Although the StAR promoter did not appear to respond to forskolin in the Figure 3b ), the overall level of transcription from the StAR promoter was not substantially affected by the Jun proteins. Thus, the distinct effects of Jun proteins on the promoters of two important steroidogenic genes under the same cellular context further support the notion that Jun represses aromatase gene expression in a promoterspecific fashion.
To assess the effect of Jun on the endogenous aromatase expression, we ectopically expressed JunB in KGN cells using a recombinant adenovirus that coexpressed JunB and the green fluorescent protein (GFP). By immunoblotting ( Figure 4a ) and visualizing green fluorescent cells following infection (data not shown), it was determined that JunB protein was overexpressed in the majority of the cell population. The infected cells were treated with forskolin and subsequently analysed for the levels of both aromatase protein ( Figure 4b ) and mRNA ( Figure 4c ). The results clearly indicate that ectopic expression of JunB inhibits the endogenous aromatase expression (compare lanes 1 and 2 with 3 and 4; Figure 4b and c).
A dominant-negative mutant of cJun antagonizes Jun-mediated repression of aromatase PII promoter To examine the role of endogenous Jun proteins in modulating the transcriptional activity of the aromatase PII promoter, we introduced a well-established dominant-negative mutant of cJun (TAM-67) that lacks the activation domain (AD) but retains the DNA-binding and dimerization domains (DBD) (Brown et al., 1993) . As expected, TAM-67 inhibited, while the full-length cJun activated, transcription from a synthetic AP1-responsive promoter (Figure 5a , right panel). In contrast, TAM-67 did not repress transcription from the aromatase PII promoter (Figure 5a , left panel). In fact, expression of TAM-67 led to a modest, but reproducible, increase in the basal level of the luciferase activity (compare columns 1 with 5 in the left panel of Figure 5a ), which is most likely due to the ability of TAM-67 to antagonize the repression of the aromatase promoter by endogenous Jun proteins. Furthermore, when TAM-67 was co-expressed with the ectopic fulllength cJun, the dominant-negative mutant was capable of partially overcoming the repressive effect of the fulllength cJun on the aromatase promoter (Figure 5b) .
The ability of TAM-67 to antagonize the Junmediated transcription repression implies that the amino-terminal AD of Jun is required for the transcription repression. To test the possibility that the carboxylterminal DNA-binding and/or dimerization domains might also be involved in the repression by the fulllength proteins, two point mutants of JunB that abolished either its dimerization (L303G) or DNA contact (K284I/C285D) capability were tested in the luciferase reporter assay (Bohmann and Tjian, 1989 ). When expressed in a level comparable to that of the wild-type Jun protein (inlet in Figure 6b ), these mutants were unable to inhibit the aromatase PII promoter (compare columns 3 and 4 with 2 in Figure 6b ). Interestingly, a mutant that lacked the N-terminal AD of JunB also failed to repress transcription (lane 5). In fact, it elevated transcription activity of the PII promoter in a similar manner as TAM-67, the dominant-negative mutant of cJun ( Figure 5 ). Thus, the results strongly indicate that both the AD and DBD of Jun are important for Jun-mediated transcriptional repression, and that the bZIP domain of cJun or JunB can act as a dominant-negative mutant to antagonize the repressive activity of the full-length proteins.
Jun proteins bind to the CRE-like sequence in the PII promoter
To map the cis-elements in the aromatase PII promoter that mediate the Jun repression, we generated a series of 5 0 deletional constructs ( Figure 7 ) and tested them in the luciferase assay for their responsiveness to Jun repression. Previous work has shown that the 1-kb upstream region of the aromatase PII promoter confers the maximal promoter activity (Fitzpatrick and Richards, 1993; Michael et al., 1995; Young and McPhaul, 1997; Hu, unpublished results) . Detailed characterization of the proximal promoter using rat or cow granulosa cells has uncovered two essential cis-acting elements, a CRE- (Figure 7a ), both of which play pivotal roles in cAMPinduced activation of the ovary-specific promoter (Morohashi et al., 1992; Fitzpatrick and Richards, 1994; Carlone and Richards, 1997; Young and McPhaul, 1997) . Consistent with previous findings, deletion of the promoter-distal sequences in PII reduced the overall promoter activity but retained the cAMP responsiveness (e.g. compare columns 1 and 2 with 10 and 11 in Figure 7b ). As expected, further removal of the sequence between À213 and À140 base pairs that contains the CLS abrogated the cAMP-responsive transcription activation (compare columns 10 and 11 with 13 and 14 in Figure 7b ). Interestingly, all cAMPresponsive deletion mutants were subject to Jun repression (columns 3, 6, 9, and 12), suggesting that the ciselement(s) that mediates the Jun action is present within the À213 bp promoter-proximal region.
The À213 bp promoter-proximal region does not contain any canonical AP1-binding sites (TGACTCA). However, several sections in this region do bear some resemblance to the AP1 consensus sequence. We therefore utilized EMSA to test the ability of these putative AP1 sites to bind to in vitro translated AP1 proteins. Interestingly, of all the oligonucleotide sequences tested, the CLS was the only one that gave rise to an AP1-specific gel shift band in EMSA (data not shown). To determine whether the same sequence could serve as a binding site for endogenous Jun proteins, EMSA was conducted using a radioactively labeled CLS-containing oligonucleotide probe and nuclear extract prepared from KGN cells pretreated with or without forskolin. Three discernable gel-shift bands were detected (I, II, and III in lanes 2 and 6; Figure 8a ). To investigate the composition of the protein-DNA complexes that these bands represented, we included in the binding reactions antibodies against JunD, cJun, or CREB (lanes 4-6, 7-9). None of the antibodies affected the intensity of band I, suggesting that it was not related to either CREB or Jun proteins. The anti-CREB antibody significantly reduced the intensity of band II while leaving band III intact (e.g. compare lane 2 with 5, and 6 with 9), indicating that band II represented a CREB-containing complex. On the other hand, the anti-cJun (lanes 4 and 8) and -JunD (lanes 3 and 7) antibodies diminished the intensity of both bands II and III while inducing additional supershift bands (indicated by asterisks), suggesting that both proteins were associated with distinct DNA-protein complexes at the CLS. The forskolin treatment did not significantly affect the gel shift pattern (compare lanes 2-5 with 6-9). An antiJunB antibody used in the same study failed to alter the gel shift pattern (data not shown), probably due to the low titer of the antibody and/or the relatively low abundance of JunB in KGN cells.
We also conducted chromatin immunoprecipitation (ChIP) to examine in vivo association of Jun with the endogenous PII promoter. KGN cells were crosslinked with formaldehyde and the sonicated chromatin fraction was subsequently immunoprecipitated with an equal amount of either rabbit IgG or an anti-cJun antibody. Following the reversal of crosslinking, the chromosomal DNA fragments were analysed by semiquantitative PCR for the presence of either the proximal region of the PII promoter or a region 2-kb upstream. As shown in Figure 8b , the proximal region of PII was preferentially precipitated by the anti-cJun antibody (compare lane 2 with 3). In contrast, no antibody-specific PCR fragments were detected with the upstream primers. This in vivo finding corroborates the EMSA result that Jun proteins are specifically associated with the PII promoter-proximal region of the aromatase gene.
Repression by Jun proteins is mediated by the CRE-like sequence
The EMSA results clearly indicate that CLS can serve as the common binding target for CREB and Jun. To ascertain whether the same CLS also confers Junmediated transcription repression, we changed CLS into a heterologous sequence (GAL4-binding site) in the context of the À316 bp promoter region. Consistent with previous findings, mutation of the CLS severely impaired the cAMP-responsive transcription activation (from >10-fold to approximately twofold; compare columns 1 and 2 in 9A with those in 9B). The residual cAMP responsiveness displayed by the mutant reporter construct could be mediated by putative CRE sequences present elsewhere in the promoter region. Importantly, the same mutant promoter became refractory to transcriptional repression by Jun (compare columns 3-6 with 1-2 in Figure 9b ). Therefore, our data strongly suggest that the CLS in the PII promoter confers dual regulatory functions for both cAMP-responsive transcriptional activation and Jun-mediated repression.
Discussion
In the current work, we provide functional evidence for an important role of Jun proteins in modulating transcription activation from the ovary-specific PII promoter of the aromatase gene. The information gathered in this study extends our current knowledge of ovarian regulation of the aromatase gene and may also provide interesting clues to dysregulation of the PII promoter in breast cancer tissue. Furthermore, the functional relationship between Jun proteins and aromatase expression may shed light on the gene regulation during maturation of ovarian follicles. Previous work with animal models and tissue culture systems strongly suggests a sequential and stage-specific pattern of hormone-dependent gene activation in ovarian follicles (Richards, 1994 (Richards, , 2001 Richards et al., 1995) . For example, FSH stimulation at the PO stage triggers two types of gene activation: the immediateearly genes such as cFos and JunB, and those that are stimulated in a more delayed fashion such as aromatase. The physiological significance and the biochemical basis of such bi-phasic gene expression patterns remain poorly understood. The transient, cAMP-mediated induction of several members of the AP1 family that precedes the aromatase expression may contribute to the delayed expression of aromatase, which could serve to ensure a controlled and coordinated hormone biosynthesis. In addition, the mRNA level of aromatase undergoes rapid and dramatic reduction following the LH surge at later stages of folliculogenesis (Hickey et al., 1988; Fitzpatrick and Richards, 1991; Richards, 1994) . Interestingly, levels of multiple AP1 proteins including JunD and Fra2 were elevated and remained high when proliferating granulosa cells turned into terminally differentiated, nondividing cells (Sharma and Richards, 2000) . In light of the strong inhibitory effect of Jun on aromatase expression observed in KGN cells, it is conceivable that AP1 proteins may play an important role in downregulating aromatase expression upon LH surge. In this regard, it will be of interest to determine whether Jun proteins could modulate expression of other ovarian genes that follow a similar expression pattern as that of aromatase during folliculogenesis. The cAMP-mediated activation of aromatase expression entails multiple regulatory steps. As such, Jun proteins could interfere with the cAMP-dependent pathway at several possible points. For example, Jun could inhibit aromatase gene activation by directly acting upon the ovary-specific promoter. Alternatively, Jun could affect any of the upstream steps along the cAMP-dependent pathway such as the intracellular cAMP level or cAMP-dependent activation of protein kinase A (PKA). It is also conceivable that Jun may induce the expression of a putative transcription repressor that in turn binds to the aromatase PII promoter. We favor the first possibility for the following reasons. First, Jun exerts quite distinct effects on the promoters of StAR and aromatase, both of which are activated by forskolin in a similar manner. Second, overexpression of JunB does not alter the overall degree of PKA-mediated CREB phosphorylation following forskolin treatment (data not shown), thus arguing against a global effect of Jun on the cAMP-mediated gene activation. Third, JunB is a much less potent transcription activator than cJun, yet both proteins repress aromatase expression with a similar efficiency. This suggests that the observed repression is less likely due to activation of another transcriptional repressor by the Jun proteins. Fourth, Jun is capable of binding to the CLS element in the PII promoter in vitro and ChIP analysis indicates that endogenous cJun is associated with the proximal region of the PII promoter. Lastly, Jun inhibits transcription in vivo via the same cAMPresponsive site in the PII promoter. Taken together, our finding supports the notion that Jun proteins antagonize the cAMP-stimulated transcription activation by directly binding to the aromatase promoter.
Upon binding to the CREB-binding site at the aromatase PII promoter, Jun proteins could utilize several possible mechanisms to antagonize the cAMPmediated transcriptional activation. For instance, Jun proteins may directly compete with CREB or related transcription activators for binding to the same CLS, thus physically blocking the association of these activators with the promoter. This simple model, albeit viable, does not explain the observation that the DNA binding-competent bZIP domain of Jun proteins, which bind DNA as efficiently as the full-length proteins, fails to repress the PII promoter. In an alternative model, Jun-containing hetero-or homodimers may bind to the CLS site and utilize the N-terminal domain of Jun to either recruit transcriptional co-repressors to the PII promoter or sequester co-activators that are present at the same promoter. Consistent with the second model, it has been shown that cJun inhibits Smad2-mediated transcription activation by recruiting the nuclear corepressor TGIF via the N-terminal domain of cJun (Pessah et al., 2001) . In a separate study, AP1 was found to repress the cAMP-stimulated expression of the 5-aminolevulinate synthase gene by sequestering the coactivator CBP, which is pivotal for transcription activation by CREB (Guberman et al., 2003) . Regardless of the specific mechanism involved, the inhibitory action of Jun must be exerted in a promoter-dependent manner, as the current study shows that Jun proteins under the same cellular context activate several other AP1-responsive promoters. Additional work is required to elucidate the cis-and trans-acting elements that confer the gene-specific effects of the Jun action.
Co-recognition of the same DNA site by both Jun and CREB family proteins provides the opportunity of both positive and negative regulation via the same cis-acting element. It has been shown previously that a common binding site for CREB and Jun in the human cJun promoter mediates dual regulation by CREB and AP-1 (Lamph et al., 1990) . In an analogous case, cJun antagonizes cAMP-mediated transcription activation of the human chorionic gonadotropin genes by CREB through a functional CREB-binding site (Pestell et al., 1994) . Conceivably, the exact transcription status of the genes under the dual control may be determined by the relative abundance of the two groups of transcription factors in a specific cellular environment. Obviously, it would be of interest to decipher the exact nucleotide sequence of the CREB/Jun-binding site that confers the dual regulation. While the current work was focused on the Jun proteins, other members of the AP1 family may also be involved in regulation of ovarian gene expression. Our effort in assessing the effect of cFos on aromatase transcription was hampered by the difficulty in ectopic expression of the protein at a level comparable to those of Jun proteins in KGN cells (data not shown). It therefore remains to be determined whether cFos and its related proteins would facilitate or oppose the action of Jun proteins in attenuating the PII promoter function.
Despite the common biochemical features shared by the different Jun proteins, they are known to play diverse and even opposing roles in cell proliferation and differentiation (Karin et al., 1997) . For example, cJun is positively involved in cell proliferation and Rasmediated oncogenesis (Mechta-Grigoriou et al., 2001; Shaulian and Karin, 2001) , whereas JunB and JunD can suppress Ras-and Src-induced cellular transformation (Johnson et al., 1996; Mechta et al., 1997; Gerald et al., 2004) . The nonoverlapping biological functions of different Jun proteins are also underscored by the distinct phenotypes of knockout mice that lack the individual Jun protein. Mice lacking cJun or JunB are embryonic lethal, though due to different tissue defects (Hilberg et al., 1993; Johnson et al., 1993; SchorppKistner et al., 1999) . On the other hand, JunD knockout mice are viable but mutant males develop hormone imbalance and impaired spermatogenesis (Thepot et al., 2000) . Thus, while our study indicates that all three Jun proteins are capable of repressing aromatase gene expression, they may contribute differentially to the regulation of aromatase expression in vivo. In this regard, it is worth noting that JunD is a major component of the AP1-DNA complex in rat granulosa cells (Sharma and Richards, 2000) . Interestingly, transgenic male mice overexpressing human aromatase exhibit defects in reproductive functions including spermatogenesis, reminiscent of the phenotypes observed with the JunD-lacking mice. Future tissuespecific knockout studies of cJun and JunB may shed more light on the relative contribution of individual Jun members to aromatase gene expression in ovaries. 
Materials and methods
Cell culture, transient transfection, and luciferase assay KGN, a human ovarian granulosa-like tumor cell line, was cultured in DMEM/F-12 medium as described previously (Nishi et al., 2001) . Transient transfection was performed using FuGene 6 transfection reagent (Roche) under optimized condition. In brief, all reporter constructs (0.25-0.5 mg) were co-transfected in the absence or presence of various expression vectors at the amounts specified in the figures. The amount of total DNA used in transfection was equalized with the pcDNA3 empty vector. Transcription efficiency was normalized by co-transfecting 250 ng of LacZ expression vector pON260 (Hu and Li, 2002) . The following day, cells were treated with forskolin at a final concentration of 25 mM for overnight. Luciferase activity in the cell lysates was determined by the single luciferase reporter assay kit (Promega), using a Monolight 3010 luminometer (Pharmingen).
Plasmid
Construction of the aromatase luciferase reporter plasmids has been described elsewhere (Wu et al., 2004) . The expression vectors for various Jun proteins have been described previously (Hu and Li, 2002) . The point mutations in the bZIP region of JunB (K284I/C285D and L303G) were introduced by PCRmediated mutagenesis. The expression construct for JunB-C was prepared by inserting a PCR-amplified fragment that encodes aa 266-347 of JunB into the BamHI/XhoI site of pcDNA3-FLAG. The aromatase-PII-Gal4 construct was prepared by PCR-mediated site-directed mutagenesis that replaced the CLS (À222/À206; 5 0 ATGCACGTCACTCTACC 3 0 ) of the PII promoter with a GAL4-binding site (5 0 CTAGAC GGAGGACTG TCCTCCGA 3 0 ). The StAR-luciferase construct used in this study contains the À153/À1 region of the promoter and was a gift from Dr LK Christenson (University of Pennsylvania) (Christenson et al., 2001 ). The collagenase-luciferase plasmid contains the À73/ þ 63 region of the promoter and was a generous gift from Dr Rosalie Uht (Lopez et al., 1993) . The cyclin D1-luciferase plasmid contains the -973 upstream region of the promoter and was a gift from Dr R Muller (Herber et al., 1994) . The synthetic AP1-luciferase reporter plasmid was purchased from Stratagene. TAM-67 was previously described (Brown et al., 1993) .
RNA isolation and semiquantitative RT-PCR assays
KGN cells were treated with forskolin and/or infected with adenoviruses as indicated in the figures. Total RNA was isolated from the cultured cells with Trizol (Invitrogen), according to specifications provided by the manufacturer. RNA (1 mg) was reverse transcribed using the oligo-dT method and the ImPrompII kit (Promega). The steady-state mRNA levels of various genes were analysed by semiquantitative PCR method. The primer sequences and PCR conditions will be provided upon request. Amplified products were resolved by 1.5% agarose gel electrophoresis, visualized by ethidium bromide staining and documented by a digital gel documentation system (AlphaImager, Alpha Innotech Corp.).
Cell extracts and Western blot analysis
Total cell lysates were prepared by lysing the cells in the SDS sample buffer. An equal amount of total protein was loaded and resolved by SDS-PAGE, and immunoblotting was performed following the manufacturer's instructions. The antibodies used were anti-JunB (sc-8051, Santa Cruz Biotechnology), anti-JunD (sc-74, Santa Cruz Biotechnology,), anticJun (sc-45, Santa Cruz Biotechnology,), anti-aromatase (MCA2077, Serotec), anti-Flag (F-3165, Sigma), anti-a-tubulin (CP06-100UG, Oncogene), and anti-b-actin (A5316, Sigma). Blots were visualized using the enhanced chemiluminescence method (ECL, Pierce Chemical Co.).
Recombinant adenovirus preparation and infection
Full-length JunB cDNA was cloned under the CMV promoter of the pAdTrack-CMV vevtor (kindly supplied by Dr B Vogelstein). Ad-JunB and Ad-LacZ constructs were made using the Ad-Easy (Q-Biogene) kit according to the manufacturer's instructions. Recombinant adenoviruses were amplified from isolated plaques in HEK293A cells by BD Adeno-X virus purification kit (cat # K1654-2, BD Biosciences), and the viral stocks were titered using Adeno-X Rapid Titer Kit (cat # K1653-1, BD Biosciences). The amount of JunBexpressing virus used for infection was determined empirically. The multiplicity of infection (MOI) ranged from 100 to 200 viral particles per cell.
Electrophoretic mobility shift assay
Nuclear lysate was prepared by extracting nuclei of KGN cells with the extraction buffer (0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 1 mM dithiothreitol, 25% (v/v) glycerol, 0.5 mM phenylmethylsulfonyl fluoride, 2 mg/ml leupeptin, 2 mg/ml pepstatin A, 1 mg/ml aprotinin, pH 7.9). Protein concentration was determined by the BCA assay (Pierce). The complementary oligonucleotides (TCAATTGGGAATG-CACGTCACTCTACCC and GTGGGTAGAGTGACGTG-CATTCCCAATT) containing the CLS site at the aromatase PII promoter were annealed and end-labeled by Klenow filling and [a-32 P]ATP. Nuclear extracts (20 mg) were incubated for 20 min at room temperature with 50 000 c.p.m. of the radiolabeled double-stranded oligonucleotide in the binding buffer containing 20 mM HEPES-KOH (pH 8.0), 50 mM KCl, 4 mM MgCl 2 , 0.2mM EDTA, 4 mM spermidine, 0.5 mM dithiothreitol, 0.05% Nonidet P-40, 20% glycerol, and 1 mg of poly(dI-dC). For the supershift experiment, 3 mg antibodies were added to the reaction mixtures that already contained the probe and nuclear lysates. The entire mixture was incubated for an additional 20 min at room temperature. The antibodies used were as follows: anti-CREB (sc-168X, Santa Cruz), anti-c-Jun (sc-45X, Santa Cruz), anti-JunD (sc-74X, Santa Cruz), and normal rabbit IgG (sc-2027, Santa Cruz). Following incubation, the protein-DNA complexes were resolved by electrophoresis in 4% nondenaturing acrylamide gels and TGE buffer (50 mM Tris-HCl, 380 mM glycine and 1 mM EDTA) at 150 V, 41C for 3.5 h, with circulation of the running buffer. The gel was pre-run for 1 h prior to the loading of the samples.
Chromatin immunoprecipitation
The ChIP experiment was performed following a previously described protocol (Aiyar et al., 2004) . Briefly, 1 Â 10 7 KGN cells were crosslinked with formaldehyde for 8 min, followed by termination of the crosslinking with 0.25 M glycine. Cell lysates were prepared and chromosomal DNA was sonicated to reach average sizes between 500 and 1000 bp. The lysate was immunoprecipitated with either rabbit IgG or an anti-cJun antibody (sc-45X). Upon reversal of the crosslinking, the purified DNA fragments were PCR-amplified for either the proximal or distal region of the aromatase PII promoter. The sequences of the primer sets used in the PCR reactions are as follows. 
